# High Dose Influenza in Immunosuppressed Subjects

> **NCT00766285** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent inactivated influenza vaccine
- **BIOLOGICAL:** Trivalent Baculovirus-expressed Influenza HA vaccine

## Key facts

- **NCT ID:** NCT00766285
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766285, "High Dose Influenza in Immunosuppressed Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00766285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*